Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial
- Bertrand Coiffier
- , Evgenii A. Osmanov
- , Xiaonan Hong
- , Adriana Scheliga
- , Jiri Mayer
- , Fritz Offner
- , Simon Rule
- , Adriana Teixeira
- , Jan Walewski
- , Sven de Vos
- , Michael Crump
- , Ofer Shpilberg
- , Dixie Lee Esseltine
- , Eugene Zhu
- , Christopher Enny
- , Panteli Theocharous
- , Helgi van de Velde
- , Yusri A. Elsayed
- , Pier Luigi Zinzani
نتاج البحث: نشر في مجلة › مقالة › مراجعة النظراء
92
اقتباسات
(Scopus)